R
2.08
0.01 (0.24%)
| Penutupan Terdahulu | 2.07 |
| Buka | 2.05 |
| Jumlah Dagangan | 292,840 |
| Purata Dagangan (3B) | 753,269 |
| Modal Pasaran | 67,061,512 |
| Harga / Pendapatan (P/E Ke hadapan) | 59.17 |
| Harga / Jualan (P/S) | 0.630 |
| Harga / Buku (P/B) | 2.26 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2024 |
| Margin Keuntungan | -5.06% |
| Margin Operasi (TTM) | 1.99% |
| EPS Cair (TTM) | -0.040 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 42.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 61.18% |
| Nisbah Semasa (MRQ) | 2.00 |
| Aliran Tunai Operasi (OCF TTM) | -4.73 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.37 M |
| Pulangan Atas Aset (ROA TTM) | -4.25% |
| Pulangan Atas Ekuiti (ROE TTM) | -28.90% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Rockwell Medical, Inc. | Menurun | Menurun |
AISkor Stockmoo
0.6
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.63 |
|
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 12.33% |
| % Dimiliki oleh Institusi | 21.27% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 7.00 (HC Wainwright & Co., 237.35%) | Beli |
| Median | 6.00 (189.16%) | |
| Rendah | 5.00 (Rodman & Renshaw, 140.96%) | Beli |
| Purata | 6.00 (189.16%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 2.30 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 23 Dec 2024 | 7.00 (237.35%) | Beli | 2.11 |
| 25 Nov 2024 | 7.00 (237.35%) | Beli | 2.31 | |
| Rodman & Renshaw | 14 Nov 2024 | 5.00 (140.96%) | Beli | 2.49 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 17 Dec 2024 | Pengumuman | Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services |
| 12 Dec 2024 | Pengumuman | Rockwell Medical Promotes Jesse Neri to Chief Financial Officer |
| 05 Dec 2024 | Pengumuman | Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System |
| 19 Nov 2024 | Pengumuman | Rockwell Medical Expands Distribution in the Philippines |
| 12 Nov 2024 | Pengumuman | Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter |
| 08 Nov 2024 | Pengumuman | Rockwell Medical Announces Date Change for Third Quarter 2024 Earnings Conference Call and Webcast |
| 14 Oct 2024 | Pengumuman | Rockwell Medical to Release Third Quarter 2024 Results on Monday, November 11, 2024 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |